We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

By LabMedica International staff writers
Posted on 06 May 2024
Print article
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe, but this often yields insufficient blood for many tests and can result in inaccurate laboratory values that vary between measurements. Now, researchers have developed an innovative device that uses microneedles and a suction cup instead of a large needle, which could be especially beneficial for those with needle phobia. This device can collect more blood than the traditional finger prick, enhancing the reliability of diagnostic measurements. Additionally, its low production cost makes it feasible for use in developing countries.

The new device for taking blood samples developed by researchers at ETH Zurich (Zurich, Switzerland) operates on a principle similar to that of a leech and is less invasive than traditional arm blood draws. It is user-friendly and can be operated by individuals without medical training. Although it does not gather as much blood as a conventional needle, it significantly surpasses the volume collected from a finger prick. The concept for this device emerged while the ETH researchers were developing a suction cup intended to administer medication through the mucous membranes inside the mouth, during which they studied how leeches attach to their hosts using a sucker and then draw blood.

The device mimics how leeches work: after attaching, they penetrate the skin with their teeth and create negative pressure to draw blood. Similarly, the new device features a suction cup about two and a half centimeters in diameter that adheres to the patient's upper arm or back. It houses a dozen microneedles that pierce the skin when pressed against it. Within minutes, the negative pressure collects enough blood for diagnostic testing. This cost-effective device could be especially useful in regions like sub-Saharan Africa, where it could significantly impact the fight against diseases such as malaria.

An additional safety feature of this device is that the microneedles are enclosed within the suction cup, reducing the risk of injury both during use and after disposal, unlike conventional needles. Currently, the suction cup is made of silicone, and the microneedles are steel, but the team is developing a version using fully biodegradable materials. While this device has been tested on pigs and extensive manufacturing details have been prepared, further optimization of the materials and safe use testing in humans are needed. The researchers are hopeful that their innovative device will soon be aiding the health of children and all who fear needles.

Related Links:
ETH Zurich 

New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Researchers have found the first evidence of testing for the alpha-synuclein protein in blood samples via seed amplification assay (Photo courtesy of Shutterstock)

Blood Test to Detect Alpha-Synuclein Protein Could Revolutionize Parkinson's Disease Diagnostics

Currently, Parkinson's disease (PD) is identified through clinical diagnosis, typically at a later stage in the disease's progression. There is a pressing need for an objective and quantifiable biomarker... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.